Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spagnoli

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Cancer Research|January 14, 2010
Modulation of T-cell activation by malignant melanoma initiating cellsTobias Schatton, Ute Schütte, Natasha Y Frank, et al.
Blood|May 29, 2000
Expression of gene MAGE-A4 in Reed-Sternberg cellsH Chambost, N Van Baren, F Brasseur, et al.
Blood|August 10, 1999
Genes encoding tumor-specific antigens are expressed in human myeloma cellsN van Baren, F Brasseur, D Godelaine, et al.
Urological Research|February 28, 2001
Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminomaR Grobholz, C S Verbeke, C Schleger, et al.
Cancers|November 27, 2021
High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall SurvivalAlexandros Lalos, Ornella Neri, Caner Ercan, et al.
Cancer Immunity|August 25, 2007
Expression of cancer-testis (CT) antigens in placentaAchim A Jungbluth, Wilson A Silva, Kristin Iversen, et al.
International Journal of Cancer|February 3, 2005
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapyUrs von Holzen, Michel Adamina, Martin Bolli, et al.
Annals of the Rheumatic Diseases|November 20, 2013
FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cellsChiara Bocelli-Tyndall, Emanuele Trella, Audrey Frachet, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Cancer Immunity|January 16, 2007
Cancer/testis (CT) antigens are expressed in fetal ovaryPeter T Nelson, Paul J Zhang, Giulio C Spagnoli, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Cancer Research|January 14, 2010
Modulation of T-cell activation by malignant melanoma initiating cellsTobias Schatton, Ute Schütte, Natasha Y Frank, et al.
Blood|May 29, 2000
Expression of gene MAGE-A4 in Reed-Sternberg cellsH Chambost, N Van Baren, F Brasseur, et al.
Blood|August 10, 1999
Genes encoding tumor-specific antigens are expressed in human myeloma cellsN van Baren, F Brasseur, D Godelaine, et al.
Urological Research|February 28, 2001
Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminomaR Grobholz, C S Verbeke, C Schleger, et al.
Cancers|November 27, 2021
High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall SurvivalAlexandros Lalos, Ornella Neri, Caner Ercan, et al.
Cancer Immunity|August 25, 2007
Expression of cancer-testis (CT) antigens in placentaAchim A Jungbluth, Wilson A Silva, Kristin Iversen, et al.
International Journal of Cancer|February 3, 2005
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapyUrs von Holzen, Michel Adamina, Martin Bolli, et al.
Annals of the Rheumatic Diseases|November 20, 2013
FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cellsChiara Bocelli-Tyndall, Emanuele Trella, Audrey Frachet, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Cancer Immunity|January 16, 2007
Cancer/testis (CT) antigens are expressed in fetal ovaryPeter T Nelson, Paul J Zhang, Giulio C Spagnoli, et al.
Pageof 19